SS Innovations International, Inc. SSII
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-07-09
SS Innovations International, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $42.5M | $20.6M | $5.9M | — | — |
| Gross profit | $19.5M | $8.5M | $725,528 | $489,594 | — |
| R&D expense | $3.7M | $2.5M | $1.1M | $83,282 | $1,000 |
| SG&A expense | $14.8M | $10.2M | $10.1M | $3.3M | — |
| Operating income | -$8.2M | -$19.0M | -$20.3M | -$5.7M | — |
| Interest expense | — | — | $523,356 | $161,999 | — |
| Income tax | $4.0M | — | — | — | — |
| Net income | -$12.1M | -$19.2M | -$20.9M | -$5.6M | -$1.5M |
| EPS (diluted) | $-0.06 | $-0.11 | $-0.14 | $-0.14 | $-0.05 |
| Operating cash flow | -$18.5M | -$9.5M | -$15.4M | -$5.6M | -$363,034 |
| Free cash flow | -$22.2M | -$10.2M | -$15.8M | -$5.8M | — |
| Cash & equivalents | $3.2M | $466,500 | $2.0M | $1.5M | $405,774 |
| Inventory | $17.1M | $10.2M | $7.0M | $855,777 | — |
| Total assets | $74.2M | $42.4M | $31.5M | $8.7M | $428,607 |
| Total liabilities | $36.0M | $28.9M | $11.8M | $11.1M | — |
| Shareholders' equity | $38.2M | $13.5M | $19.7M | -$2.7M | -$166,380 |
Source: SEC EDGAR filings · CIK 0001676163 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.